کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6262004 | 1290787 | 2012 | 8 صفحه PDF | دانلود رایگان |

Parkinson disease (PD) is the second most common neurodegenerative disease, and it cannot be completely cured by current medications. In this study, DJ-1 protein was administrated into medial forebrain bundle of PD model rats those had been microinjected with 6-hydroxydopamine (6-OHDA) or MG-132. We found that DJ-1 protein could reduce apomorphine-induced rotations, inhibit reduction of dopamine contents and tyrosine hydroxylase levels in the striatum, and decrease dopaminergic neuron death in the substantia nigra. In 6-OHDA lesioned rats, uncoupling protein-4, uncoupling protein-5 and superoxide dismutase-2 (SOD2) mRNA and SOD2 protein were increased when DJ-1 protein was co-injected. Simultaneously, administration of DJ-1 protein reduced α-synuclein and hypoxia-inducible factor 1α mRNA and α-synuclein protein in MG-132 lesioned rats. Therefore, DJ-1 protein protected dopaminergic neurons in two PD model rats by increasing antioxidant capacity and inhibiting α-synuclein expression.
⺠MG-132 iMFB induced a sustained DA neuron degeneration in rats. ⺠DJ-1 protein protected dopamine neurons from MG-132 insults. ⺠DJ-1 protein increased the expression of UCP4, UCP5 and SOD2 in PD rats. ⺠DJ-1 protein decreased the expression of α-synuclein and HIF-1 α in PD rats.
Journal: Brain Research Bulletin - Volume 88, Issue 6, 1 September 2012, Pages 609-616